
The PEPTIDE study is a randomized controlled trial that aims to establish a protocol for quantifying the multi-route exposure of medical staff to infectious particles during oesophagogastroduodenoscopy (OGD) procedures. The study will enrol 130 participants who undergo OGD procedures while an anthropomorphic model with respiratory-related morphology and function is placed beside them. The primary outcome will be the model's airway dosage of exhaled infectious particles, and the secondary outcome will be the model's facial mucosa dosage of exhaled infectious particles. The study will be conducted at a tertiary hospital in China using quantitative methods. The results will be disseminated through conferences and peer-reviewed journals. Ethical approval has been obtained, and participants will provide written informed consent.
Like
Save
Share